Patient Return Electrodes Market revenue to surpass USD 343 Million by 2035, says Research Nester
Major patient return electrode market players include Pfizer Inc., Medtronic Plc, Boston Scientific Corporation, Stryker Corporation, Olympus Corporation, Conmed Corporation, Utah Medical Products, Inc., KLS Martin GmbH & Co. KG, Arthrex GmbH and AtriCure Inc.,
New York, Aug. 24, 2023 (GLOBE NEWSWIRE) — The global patient return electrodes market size is poised to grow at a CAGR of over ~7% from 2023 to 2035. The market is anticipated to garner a revenue of USD 343 million by the end of 2035, up from a revenue of ~USD 180 million in the year 2022.owing to the increasing popularity of electrosurgery in various surgical procedures and the rising prevalence of chronic diseases such as cancer and heart disease, which require surgical treatments. Approximately 10 million deaths worldwide are predicted to be caused by cancer in 2020, according to the World Health Organization. An estimated 19.3 million new cancer cases and nearly 10.0 million cancer deaths occurred worldwide in 2020, according to the American Cancer Society. Electrosurgery is used to treat conditions such as cancer, benign tumors, and ulcers.
Request Free Sample Copy of this Report @ in the North American region is estimated to garner the largest revenue by the end of 2035, owing to the presence of a large patient pool and the high adoption rate of advanced medical technologies in the region. Furthermore, the region is home to a large patient population suffering from various cardiovascular diseases such as coronary heart disease, peripheral arterial disease, aortic disease, and arrhythmias. According to the Centers for Disease Control and Prevention, in the United States, heart disease is the number one cause of death. In the United States, a person dies from a cardiovascular disease every 34 seconds, and 697,000 people died from a heart disease in 2020. Patient-return electrodes allow for the delivery of a controlled electrical impulse to the heart muscle, which helps to improve the coordination of the heart’s contractions and restore the normal rhythm of the heart. This helps ensure that the electrical current is distributed evenly over the patient’s chest, which helps reduce the risk of tissue damage. Moreover, the increased investment in healthcare infrastructure and the easy availability of patient return electrode products in the region are expected to further propel market growth in the region.
Make an Inquiry Before Buying this Report @ https://www.researchnester.com/inquiries-before-buying-4028
Upsurge in the Number of Surgical Procedures to Drive Growth in the Asia-Pacific Region
The patient return electrodes market in the Asia Pacific region is estimated to garner the highest CAGR by the end of 2035 owing to the increasing awareness regarding the use of patient return electrodes in gynecology surgeries and the increasing number of gynecology-related diagnostic and therapeutic procedures being performed in the region. The growing number of surgical procedures in the region is also expected to drive market growth. It was observed that over 80 million surgical procedures were performed in Chinese hospitals in 2021. Return electrodes are used to help maintain a steady current flow during a surgical procedure. This helps to ensure that the patient’s body remains at a constant electrical potential and reduces the risk of tissue damage. As the population ages, the demand for surgery is increasing, particularly in developing countries. As a result, there has been an increase in the number of medical facilities offering these procedures, which in turn has increased the demand for patient return electrodes. Moreover, the rising demand for medical devices in the region, the growing awareness among the population about the safety implications of using medical devices, and the presence of a large patient population in the region are expected to drive the growth of the market.
Patient Return Electrodes, Segmentation by Type
- Reusable
- Disposable
- Others
The reusable patient return electrodes segment in patient return electrodes market is anticipated to hold the largest revenue by the end of 2035 as a result of their superior performance and durability, as well as their low cost and ease of use compared to other types of electrodes. Additionally, this type of electrode is becoming increasingly popular in monitoring applications owing to its ability to provide accurate readings. Furthermore, these electrodes are reusable, which helps reduce the cost of purchasing new electrodes and the amount of waste generated. They are also more comfortable for the patient, which is beneficial for long-term monitoring applications. Also, a new generation of reusable patient return electrodes, developed by leading manufacturers, is also predicted to drive growth in the segment. For instance, a newly developed reusable patient return electrode has been introduced by Ethicon, a Johnson & Johnson Medical Devices Company. The unique design of the product provides a soft surface that contours to the patient’s body to reduce pressure points and allow even weight distribution. The electrodes also feature a reusable design, which helps to reduce costs and waste.
Patient Return Electrodes, Segmentation by Patient Type
- Adults
- Pediatric
- Geriatric
The geriatric segment in patient return electrodes market is anticipated to hold the largest revenue by the end of 2035, backed by the growing population of elderly people and the increasing prevalence of chronic diseases, which require the use of patient-return electrodes for monitoring vital signs. For instance, in India, two out of three seniors suffer from some type of chronic disease. And approximately 46% of the chronic disease burden is expected to be carried by the elderly by 2030. As the elderly population continues to grow, there is an increased need for healthcare solutions that can assist in monitoring vital signs. Patient return electrodes are one such solution and are used in conjunction with a variety of medical devices and equipment. Therefore, as the elderly population continues to grow, the demand for patient return electrodes is expected to increase, thereby contributing to increased revenue in the geriatric segment of the patient return electrodes market.
Request for Customization of this Report @ https://www.researchnester.com/customized-reports-4028
Patient Return Electrodes, Segmentation by End User
- Hospitals
- Ambulatory Surgical Centers
- Research Laboratories
- Academic Institutes
- Others
Few of the well-known industry leaders in the patient return electrodes market that are profiled by Research Nester are are Pfizer Inc., Medtronic Plc, Boston Scientific Corporation, Stryker Corporation, Olympus Corporation, Conmed Corporation, Utah Medical Products, Inc., KLS Martin GmbH & Co. KG, Arthrex GmbH and AtriCure Inc., and other key market players.
Recent Development in the Patient Return Electrodes Market
- The Stryker Company acquired Vocera Communications, Inc., a company specializing in care coordination and communication through digital technology. This acquisition presents significant opportunities for innovation and accelerating digital ambitions.
- A new implant production facility has been inaugurated by Karl Leibinger Medizintechnik GmbH & Co KG. The facility is equipped with the latest digital production technologies and will enable the company to produce customized medical implants in a cost-efficient way.
About Research Nester
Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.
CONTACT: AJ Daniel Corporate Sales, USA Research Nester Email: [email protected] USA Phone: +1 646 586 9123 Europe Phone: +44 203 608 5919
